BioStock: PHI´s CEO comments on latest advancements

In 2022, medtech company Phase Holographic Imaging conducted a rights issue that added over 57 million SEK to its coffers. Since then, and with a new focus on regenerative medicine, the company has been attracting more attention, not least by adding the Swiss investor company Altium as a new major shareholder. BioStock reached out to PHI´s CEO, Patrik Eschricht, to learn more about the visions moving forward.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2023/03/phis-ceo-comments-on-latest-advancements/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/